Literature DB >> 26884864

PAI-1 and TNF-α profiles of adipose tissue in obese cardiovascular disease patients.

Sema Bilgic Gazioglu1, Gokce Akan2, Fatma Atalar2, Gaye Erten1.   

Abstract

UNLABELLED: Obesity as a leading preventable cause of death worldwide is closely linked to cardiovascular disease (CVD). Plasma plasminogen activator inhibitor (PAI)-1, a potent inhibitor of plasminogen activation and fibrinolysis, is increased in many clinical situations associated with high incidence of CVD. In the obesity-linked elevation of PAI-1, evidence points to TNF-α as an important regulator of PAI-1 expression in adipose tissue.
BACKGROUND: This study aims to evaluate mediastinal PAI-1 and TNF-α mRNA levels in adipose tissues (AT) and compare serum levels in obesity with and without coronary artery disease (CAD). PATIENTS AND METHODS: Obese patients with (n=37) and without CAD (n=20) were included in the study.
RESULTS: The serum levels of PAI-1 and TNF-α were significantly higher in obese patients with CAD compared to obese patients without CAD. PAI-1 mRNA expression was significantly increased in mediastinal adipose tissue (MAT) of obese patients with CAD compared to those without CAD, TNF-α mRNA expressions were found to be higher in EAT (epicardial AT), MAT and SAT (subcutaneous AT) of obese patients with CAD.
CONCLUSIONS: The study demonstrated a close direct relationship between TNF-α and PAI-1. PAI-1 mRNA expression strongly correlated positively with serum TNF-α in MAT, and TNF-α expressions with PAI-1 serum levels.

Entities:  

Keywords:  PAI-1; TNF-α; adipose tissue; cardiovascular disease

Mesh:

Substances:

Year:  2015        PMID: 26884864      PMCID: PMC4730077     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  26 in total

Review 1.  Increased plasminogen activator inhibitor-1 and vasculopathy. A reconcilable paradox.

Authors:  B E Sobel
Journal:  Circulation       Date:  1999-05-18       Impact factor: 29.690

Review 2.  PAI-1 and the metabolic syndrome: links, causes, and consequences.

Authors:  Marie-Christine Alessi; Irène Juhan-Vague
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-08-24       Impact factor: 8.311

Review 3.  Fat cell function and fibrinolysis.

Authors:  M C Alessi; P Morange; I Juhan-Vague
Journal:  Horm Metab Res       Date:  2000 Nov-Dec       Impact factor: 2.936

4.  Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus.

Authors:  Y Mishima; A Kuyama; A Tada; K Takahashi; T Ishioka; M Kibata
Journal:  Diabetes Res Clin Pract       Date:  2001-05       Impact factor: 5.602

5.  Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits.

Authors:  Delphine Bastelica; Pierre Morange; Bruno Berthet; Hélène Borghi; Odile Lacroix; Michel Grino; Irène Juhan-Vague; Marie-Christine Alessi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-01       Impact factor: 8.311

Review 6.  Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease.

Authors:  Claudia Dellas; David J Loskutoff
Journal:  Thromb Haemost       Date:  2005-04       Impact factor: 5.249

7.  Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.

Authors:  M C Alessi; D Bastelica; P Morange; B Berthet; I Leduc; M Verdier; O Geel; I Juhan-Vague
Journal:  Diabetes       Date:  2000-08       Impact factor: 9.461

Review 8.  Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk.

Authors:  I Juhan-Vague; M-C Alessi; A Mavri; P E Morange
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

9.  Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site.

Authors:  Baidong Hou; Mesut Eren; Corrie A Painter; Joseph W Covington; John D Dixon; John A Schoenhard; Douglas E Vaughan
Journal:  J Biol Chem       Date:  2004-02-12       Impact factor: 5.157

10.  Human epicardial adipose tissue is a source of inflammatory mediators.

Authors:  Tomasz Mazurek; LiFeng Zhang; Andrew Zalewski; John D Mannion; James T Diehl; Hwyda Arafat; Lea Sarov-Blat; Shawn O'Brien; Elizabeth A Keiper; Anthony G Johnson; Jack Martin; Barry J Goldstein; Yi Shi
Journal:  Circulation       Date:  2003-10-27       Impact factor: 29.690

View more
  11 in total

1.  Increased expression of plasminogen activator inhibitor-1 (PAI-1) is associated with depression and depressive phenotype in C57Bl/6J mice.

Authors:  René A Girard; Prashant S Chauhan; Torry A Tucker; Tim Allen; Jaswinder Kaur; Ann Jeffers; Kathleen Koenig; Galina Florova; Andrey A Komissarov; Tatiana A Gaidenko; Mignote B Chamiso; James Fowler; Danna E Morris; Krishna Sarva; Karan P Singh; Steven Idell; Richard D Idell
Journal:  Exp Brain Res       Date:  2019-11-16       Impact factor: 1.972

2.  Association between new circulating proinflammatory and anti-inflammatory adipocytokines with coronary artery disease.

Authors:  Tong Liu; Chao Han; Lixian Sun; Zhenjiang Ding; Fei Shi; Ruijuan Wang; Wenfeng Wang; Weichao Shan; Ying Zhang; Na Hu; Jingyi Liu; Haiwei Bu
Journal:  Coron Artery Dis       Date:  2019-11       Impact factor: 1.439

Review 3.  The Role of Secretory Activity Molecules of Visceral Adipocytes in Abdominal Obesity in the Development of Cardiovascular Disease: A Review.

Authors:  Yuliya I Ragino; Ekaterina M Stakhneva; Yana V Polonskaya; Elena V Kashtanova
Journal:  Biomolecules       Date:  2020-02-28

4.  Plasminogen Activator Inhibitor-1 in poorly controlled vs well controlled Type-2 Diabetes Mellitus patients: A case-control study in a district hospital in Ghana.

Authors:  Charles Nkansah; Otchere Addai-Mensah; Kofi Mensah; Michael Owusu; Richard K D Ephraim; Patrick Adu; Felix Osei-Boakye; Samuel K Appiah; Dorcas Serwaa; Charles A Derigubah; Alexander Yaw Debrah
Journal:  PLoS One       Date:  2021-04-15       Impact factor: 3.240

Review 5.  Gut Microbiome, Inflammation, and Cerebrovascular Function: Link Between Obesity and Cognition.

Authors:  Lisette Olsthoorn; Debby Vreeken; Amanda J Kiliaan
Journal:  Front Neurosci       Date:  2021-12-06       Impact factor: 4.677

6.  The Astragaloside IV Derivative LS-102 Ameliorates Obesity-Related Nephropathy.

Authors:  Ziyu Li; Wei Yang; Yong Yang; Jianbo Wu; Pei Luo; Yong Liu
Journal:  Drug Des Devel Ther       Date:  2022-03-14       Impact factor: 4.162

7.  HA and HS Changes in Endothelial Inflammatory Activation.

Authors:  Elena Caravà; Paola Moretto; Ilaria Caon; Arianna Parnigoni; Alberto Passi; Evgenia Karousou; Davide Vigetti; Jessica Canino; Ilaria Canobbio; Manuela Viola
Journal:  Biomolecules       Date:  2021-05-29

8.  Histone deacetylase 2 (HDAC2) attenuates lipopolysaccharide (LPS)-induced inflammation by regulating PAI-1 expression.

Authors:  Wen-Feng Fang; Yu-Mu Chen; Chiung-Yu Lin; Hui-Lin Huang; Hua Yeh; Ya-Ting Chang; Kuo-Tung Huang; Meng-Chih Lin
Journal:  J Inflamm (Lond)       Date:  2018-01-10       Impact factor: 4.981

9.  Pro-atherogenic mediators and subclinical atherogenesis are related to epicardial adipose tissue thickness in patients with cardiovascular risk.

Authors:  Juan A Peraza-Zaldívar; Juan A Suárez-Cuenca; Rocío Aceves-Millán; Carlos Ixcamparij-Rosales; Lilia Amezcua; Rebeca Pérez-Cabeza de Vaca; Nuria Guerrero-Celis; Alberto Melchor-López; Paul Mondragón-Terán; Sofía L Alcaráz-Estrada
Journal:  J Int Med Res       Date:  2016-08-07       Impact factor: 1.671

Review 10.  Abdominal Obesity, Adipokines and Non-communicable Diseases.

Authors:  Deepika Dhawan; Sheel Sharma
Journal:  J Steroid Biochem Mol Biol       Date:  2020-08-18       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.